Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung cancer screening.

Peter B Bach1

  • 1Memorial Sloan-Kettering Cancer Center, New York, New York10021, USA. bachp@mskcc.org.

Journal of the National Comprehensive Cancer Network : JNCCN
|April 2, 2008
PubMed
Summary
This summary is machine-generated.

Early lung cancer diagnosis remains a challenge. Current screening methods like chest X-rays and CT scans have not proven effective in detecting curable lung cancer early without significant harm.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection-Reply.

Cancer discovery·2026
Same author

Patina of precision: risk models for lung cancer screening eligibility.

BMJ oncology·2025
Same author

Cancer treatment monitoring using cell-free DNA fragmentomes.

Nature communications·2024
Same author

Quality of Treatment Selection for Medicare Beneficiaries With Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Innovations in Early Lung Cancer Detection: Tracing the Evolution and Advancements in Screening.

Journal of clinical medicine·2024
Same author

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection.

Cancer discovery·2024
Same journal

A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
See all related articles

Area of Science:

  • Oncology
  • Radiology
  • Pulmonology

Background:

  • Lung cancer often diagnosed at incurable advanced stages.
  • Need for early detection methods with minimal side effects.
  • Existing screening modalities lack proven efficacy.

Purpose of the Study:

  • Evaluate current lung cancer screening approaches.
  • Assess the potential of computed tomography (CT) scanning for early detection.
  • Determine if screening alters lung cancer's natural history.

Main Methods:

  • Review of decades of research on lung screening.
  • Analysis of chest radiograph, sputum cytology, and CT scanning.
  • Consideration of evidence from randomized trials.

Related Experiment Videos

Main Results:

  • No current screening method reliably detects early-stage lung cancer.
  • Computed tomography (CT) scanning shows potential but requires further study.
  • Benefits of current screening methods do not outweigh harms.

Conclusions:

  • No established screening recommendations for lung cancer exist.
  • Future randomized trials on CT screening may alter current guidelines.
  • Early detection of lung cancer remains a critical unmet need.